Registry following teenagers with atopic dermatitis under dermatology care
Collects long-term information on how atopic dermatitis treatments are used in adolescents.
Key facts
- Who runs it
- CorEvitas
- Where
- Waltham, United StatesSee the site
- Trial code
- Registry title
- CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- 2 Dec 2023
- Expected to end
- 31 Dec 2099
- Type of study
- Observational
- Record updated
- 29 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for young people aged 10 to 15 with moderate to severe atopic dermatitis, diagnosed by a dermatologist or other qualified healthcare provider.
- Age
- 10 to 15 years old at enrollment.
- Sex
- All sexes can join.
- Disease stage
- Moderate to severe atopic dermatitis.
- Earlier treatment
- The person has started, or is starting, a medication that qualifies for the registry at enrollment.
Main reasons for not taking part
- Taking part in, or planning to take part in, a blinded clinical trial for an atopic dermatitis drug
- Unwilling or unable to have standing height measured
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- To be eligible to participate in this registry, an individual must meet all the following criteria:; Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider; Is 10 - 15 years of age at the time of enrollment; Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment
Who cannot take part
- An individual who meets any of the following criteria will be excluded from participation in the registry:; Is participating or planning to participate in a blinded clinical trial for an AD drug; Is unwilling or unable to provide standing height measurements
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 15 years old?
Where in United States
- CorEvitas, LLCWaltham, United StatesContact: Cathy CheneyTaking people
About the trial
What the trial wants to find out
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- Plain-language title
- Registry following teenagers with atopic dermatitis under dermatology careGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06238765, who can take part
- Record updated
- 29 June 2026